Search Orphan Drug Designations and Approvals
-
Generic Name: | ubidecarenone |
---|---|
Date Designated: | 11/08/2017 |
Orphan Designation: | Treatment of pancreatic cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BPGbio, Inc Headquarters & Innovation Center 500 Old Connecticut Path, Building B Framingham, Massachusetts 01701 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-